Issued Patents All Time
Showing 1–17 of 17 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10352936 | Use of tumor Fas expression to determine response to anti-cancer therapy | Jaime F. Modiano, Donald Bellgrau | 2019-07-16 |
| 9216206 | Methods of treating symptoms associated with menopause and hormonal variations with G-CSF | Debra M. Duke | 2015-12-22 |
| 8821892 | Yeast-based therapeutic for chronic hepatitis C infection | Alex Franzusoff, Aurelia Haller, Thomas H. King | 2014-09-02 |
| 8728489 | Immunotherapy for chronic hepatitis C virus infection | David Apelian, Alex Franzusoff | 2014-05-20 |
| 8715645 | Viral vectors encoding apoptosis-inducing proteins and methods for making and using the same | Donald Bellgrau, Jerome Schaack | 2014-05-06 |
| 8388980 | Yeast-based therapeutic for chronic hepatitis C infection | Alex Franzusoff, Aurelia Haller, Thomas H. King | 2013-03-05 |
| 8221763 | Yeast-antigen compositions and methods of using the same | Donald Bellgrau, Alex Franzusoff, Cara C. Wilson | 2012-07-17 |
| 8007816 | Yeast-based therapeutic for chronic hepatitis C infection | Alex Franzusoff, Aurelia Haller, Thomas H. King | 2011-08-30 |
| 7736642 | Yeast-based vaccine for inducing an immune response | Alex Franzusoff, Aurelia Haller, Thomas H. King, Yingnian Lu, Victoria Kelley Hodson | 2010-06-15 |
| 7632511 | Yeast-based therapeutic for chronic hepatitis C infection | Alex Franzusoff, Aurelia Haller, Thomas H. King | 2009-12-15 |
| 7625569 | Yeast-based therapeutic for chronic hepatitis C infection | Alex Franzusoff, Aurelia Haller, Thomas H. King | 2009-12-01 |
| 7595060 | Yeast-antigen compositions methods of making the same | Donald Bellgrau, Alex Franzusoff, Cara C. Wilson | 2009-09-29 |
| 7439042 | Yeast-based therapeutic for chronic hepatitis C infection | Alex Franzusoff, Aurelia Haller, Thomas H. King | 2008-10-21 |
| 7083787 | Yeast-dendritic cell vaccines and uses thereof | Donald Bellgrau, Alex Franzusoff, Cara C. Wilson | 2006-08-01 |
| 6325999 | Use of Fas ligand to suppress T-lymphocyte-mediated immune responses | Donald Bellgrau | 2001-12-04 |
| 5830463 | Yeast-based delivery vehicles | Alex Franzusoff, Donald Bellgrau | 1998-11-03 |
| 5759536 | Use of fas ligand to supress T-lymphocyte-mediated immune responses | Donald Bellgrau | 1998-06-02 |